http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101577392-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-304 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-076 |
| filingDate | 2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101577392-B1 |
| titleOfInvention | A composition for preventing, ameliorating or treating a Th1-mediated immune disease or a Th2-mediated immune disease comprising an extract of Bombyx mori, |
| abstract | The present invention relates to a composition for preventing, ameliorating or treating a Th1-mediated immune disease or a Th2-mediated immune disease comprising an extract of Poria cocos Bark as an active ingredient. According to the present invention, the extract of Bombyx mori extract has a Th1-mediated immune disease or a Th2-mediated immune disease because it inhibits IL-4 and IL-10 production, inhibits degranulation of mast cells, induces differentiation into Treg cells, Prevention, improvement, or treatment. |
| priorityDate | 2012-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 216.